For many lung cancer patients, Keytruda is a better initial treatment than chemotherapy, study finds
In findings that may allow many lung cancer patients to avoid chemotherapy, a large clinical trial has shown that the immunotherapy drug Keytruda is a more effective initial treatment for two-thirds of patients with the most common type of lung cancer.Compared with advanced small-cell lung cancer...
Source: Los Angeles Times - Science - Category: Science Authors: Melissa Healy Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Immunotherapy | Lung Cancer | Science | Study